- •Patients with heart disease have health preferences that are systematically different from those of the general public.
- •This study provides utility values for 5-level EQ-5D health states based on the preferences of patients with heart disease.
- •This value set is useful for clinical decision making and for economic evaluation aiming to use patient preferences to inform treatment selection or reimbursement for patients with heart disease.
- •The utility index derived from this value set could be also used as a measure of health-related quality of life for patients with heart disease.
Purchase one-time access:Academic and Personal
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- World population ageing 2017. Union Nations, Department of Economic and Social Affairs Population Division.Accessed January 2021)
- Should health technology assessment be more patient centric? If so, how?.Eur J Health Econ. 2020; 21: 1117-1120
- 2015 global survey on health technology assessment by national authorities. World health organization.https://www.who.int/health-technology-assessment/MD_HTA_oct2015_final_web2.pdfDate accessed: January 15, 2021
- Whom should we ask? A systematic literature review of the arguments regarding the most accurate source of information for valuation of health states.Qual Life Res. 2020; 29: 1465-1482
- Experience-based values: a framework for classifying different types of experience in health valuation research.Patient Patient Centered Outcomes Res. 2018; 11: 253-270
- General guidelines for economic evaluations from the Dental and Pharmaceutical Benefits Agency (TLVAR 2017:1). TLV.Accessed January 2021)
- Drug Evaluation Methods and Process Guide. 2nd version ACE.https://www.ace-hta.gov.sg/docs/default-source/process-methods/ace-methods-and-process-guide-for-drug-evaluation-(20-dec-2019).pdf(Accessed January 2021)
- Medical Technologies Methods and Process Guide. 1st version. ACE.http://www.ace-hta.gov.sg/public-data/our-process-and-methods/ACE%20methods%20and%20process%20guide%20for%20medical%20technologies%20evaluation%20(1%20Oct%202018).pdf(Accessed January 2021)
- World health statistics. World Health Organization.Accessed January 2021)
- Comparison of health state values derived from patients and individuals from the general population.Qual Life Res. 2017; 26: 3353-3363
- Do chronic disease patients value generic health states differently from individuals with no chronic disease? A case of a multicultural Asian population.Health Qual Life Outcomes. 2015; 13: 8
- The effect of chronic conditions on stated preferences for health.Eur J Health Econ. 2013; 14: 697-702
- Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990-2015.J Am Coll Cardiol. 2017; 70: 1-25
- Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study.Qual Life Res. 2013; 22: 1717-1727
- Census of population 2010 statistical release 1. Demographic characteristics, education, language and religion. Singapore Department of Statistics.https://www.singstat.gov.sg/docs/default-source/default-document-library/publications/publications_and_papers/cop2010/census_2010_release1/cop2010sr1.pdf(Accessed January 2021; Published 2010)
- Quality control process for EQ-5D-5L valuation studies.Value Health. 2017; 20: 466-473
- A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol.Value Health. 2014; 17: 445-453
- EuroQol protocols for time trade-off valuation of health outcomes.Pharmacoeconomics. 2016; 34: 993-1004
- EQ-5D-5L user guide. EuroQol Research Foundation.Accessed May 2021)
- Interpretation and use of the 5-level EQ-5D response labels varied with survey language among Asians in Singapore.J Clin Epidemiol. 2015; 68: 1195-1204
- Cross-cultural measurement equivalence of the EQ-5D-5L items for English-speaking Asians in Singapore.Qual Life Res. 2015; 24: 1565-1574
- The HeartQoL: Part I. Development of a new core health-related quality of life questionnaire for patients with ischemic heart disease.Eur J Prev Cardiol. 2014; 21: 90-97
- Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels.9th ed. Lippincott Williams and Wilkins, Boston, MA1994
- Grading of angina pectoris.Circulation. 1976; 54: 522-523
- Sample size determination for EQ-5D-5L value set studies.Qual Life Res. 2017; 26: 3365-3376
- Less is more: cross-validation testing of simplified nonlinear regression model specifications for EQ-5D-5L health state values.Value Health. 2017; 20: 945-952
- Modeling valuations for EuroQol health states.Med Care. 1997; 35: 1095-1108
- Estimating an EQ-5D-5L value set for China.Value Health. 2017; 20: 662-669
- xreg: flexible, multi-data.frame maximum likelihood-based regression functions in R. GitHub.Accessed January 2021)
- R: A language and environment for statistical computing. R Foundation for Statistical Computing.Accessed January 2021)
- Valuation of EQ-5D-3L health states in Singapore: modeling of time trade-off values for 80 empirically observed health states.Pharmacoeconomics. 2014; 32: 495-507
- A time trade-off-derived value set of the EQ-5D-5L for Canada.Med Care. 2016; 54: 98
- Valuing health-related quality of life: an EQ-5 D-5 L value set for E ngland.Health Econ. 2018; 27: 7-22
- Dutch tariff for the five-level version of EQ-5D.Value Health. 2016; 19: 343-352
- Prevalence and correlates of heart disease among adults in Singapore.Asian J Psychiatry. 2016; 19: 37-43
- QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30.Qual Life Res. 2016; 25: 625-636
- Australian utility weights for the EORTC QLU-C10D, a multi-attribute utility instrument derived from the cancer-specific quality of life questionnaire, EORTC QLQ-C30.Pharmacoeconomics. 2018; 36: 225-238
- UK utility weights for the EORTC QLU-C10D.Health Econ. 2019; 28: 1385-1401